Submitted:
13 November 2026
Posted:
17 November 2026
You are already at the latest version
Abstract
The tumor suppressor gene p53 plays a central role in tumor suppression and is the most frequently mutated gene in human cancers; p53 mutation is most often associated with reduction or loss of function of p53. Panc-1 cells harbor p53 mutations and overexpress cyclin D1, making them resistant to drugs that induce p53-dependent apoptosis. 3EE, 20Ac-ingenol activates p53 in these cells via ATR/ATM activation, which induces the expression of p21 and PTEN, thereby inducing apoptosis through reactivation of mutant p53 in the Panc-1 cells. It has also been reported that mutant p53 can be reactivated in an ARF-dependent manner and induce p53-dependent apoptotic pathways. ARF expression is known to be induced through coactivation of the KRAS/β-catenin signal and DNA damage pathway associated with Cdk2/E2F1 expression. In Panc-1 cells with elevated cyclin D1 expression due to KRAS activation, 3EE, 20Ac-ingenol increases Cdk2/E2F1 expression via replication stress; consequently, it can induce ARF expression through a cooperative effect with the RAS/β-catenin activation pathway and the Cdk2/E2F1 expression cascade via ATM/ATR activation, resulting in ARF-dependent activation of mutant p53. Furthermore, it has been reported that ARF-expressing pancreatic cancer cells exhibit specific tumor-suppressive effects independent of p53 via methylation of ARF. The detection of ARF expression in Panc-1 cells suggests the potential for both p53-dependent and p53-independent induction of apoptosis of these cells. In contrast to Panc-1 cells MCF-7 cells induced p53-independent p21 overexpression and apoptosis.
Keywords:
K-RAS
; p14ARF
; PTEN
; p53
; MDM2
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.